Rohto Pharmaceutical Revenue

In the fiscal year ending March 31, 2025, Rohto Pharmaceutical had annual revenue of 308.63B JPY with 13.95% growth. Rohto Pharmaceutical had revenue of 82.73B in the quarter ending March 31, 2025, with 18.73% growth.

Revenue

308.63B

Revenue Growth

+13.95%

P/S Ratio

1.51

Revenue / Employee

33.75M

Employees

9,144

Market Cap

465.60B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	308.63B	37.79B	13.95%
Mar 31, 2024	270.84B	32.18B	13.48%
Mar 31, 2023	238.66B	39.02B	19.54%
Mar 31, 2022	199.65B	18.36B	10.13%
Mar 31, 2021	181.29B	-7.04B	-3.74%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Japan Tobacco	3,236.41B
Seven & i Holdings	11.97T
Ajinomoto Co.	1,530.56B
Kao Corporation	1,652.51B
Pan Pacific International Holdings	2,215.91B
Asahi Group Holdings	2,953.23B
Unicharm	980.22B
Kirin Holdings Company	2,382.48B

Revenue Rankings